Publication type: Article in scientific journal
Type of review: Peer review (publication)
Title: Pharmacologically induced angiogenesis in transgenic zebrafish
Authors: Raghunath, Michael
Wong, Yuan Sy
Farooq, Muhammad
Gee, Ruowen
DOI: 10.1016/j.bbrc.2008.11.127
Published in: Biochemical and Biophysical Research Communications
Volume(Issue): 378
Issue: 4
Pages: 766
Pages to: 771
Issue Date: 2009
Publisher / Ed. Institution: Elsevier
ISSN: 0006-291X
Language: English
Subject (DDC): 571: Physiology and related subjects
572: Biochemistry
Abstract: The rapid vascularisation of biomaterials and engineered tissue after implantation is a current unmet need. To this end, we explored the pharmacological option of inducing neovascularisation using compounds that inhibit hypoxia-induced factor-1α prolyl hydroxylase. This stabilises hypoxia inducible factor-1α and therefore de-repress the transcription of various angiogenic genes. In the quest for a small vertebrate model allowing for in vivo screening we exposed transgenic zebrafish embryos exhibiting fluorescent blood vessels to hydralazine hydrochloride and 2,4-pyridine dicarboxylic acid from 6 hpf to 72 hpf by immersion. Live observation of embryos revealed that the substances induced formation of ectopic blood vessels in the subintestinal vessel basket. We confirmed the HIF-stabilising effects biochemically in human fibroblasts and with an in vitro angiogenesis fibroblast/HUVEC co-culture model. Cross-inhibition of collagen prolyl hydroxylase was confirmed by reduced collagen secretion by fibroblasts and reduced collagen content of zebrafish embryos.
Fulltext version: Published version
License (according to publishing contract): Licence according to publishing contract
Departement: Life Sciences and Facility Management
Organisational Unit: Institute of Chemistry and Biotechnology (ICBT)
Appears in collections:Publikationen Life Sciences und Facility Management

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.